Ringstad joins from Campbell Conroy & O’Neil, where he represented clients in complex national mass tort and toxic tort litigation. His experience includes defending pharmaceutical companies, businesses, and individuals against high-exposure personal injury claims involving pharmaceutical products, opioids, and environmental contamination.
Throughout his career, Ringstad has managed large-scale pharmaceutical mass tort dockets and developed scientific litigation strategies involving toxicology, epidemiology, and industrial hygiene. He has also represented water utilities and environmental engineering companies in class action lawsuits involving drinking water quality and contamination.
His litigation experience spans all stages of complex disputes, including pleadings, discovery, depositions, expert witness challenges, summary judgment proceedings, and trial preparation.
Ringstad’s arrival also reunites him with former colleagues, including Ryan O’Neil, who joined Troutman Pepper Locke earlier in 2026.
Schreck joins from Arnold & Porter Kaye Scholer LLP, where she represented pharmaceutical and medical device companies in complex federal and state litigation, government enforcement proceedings, and internal investigations.
Her practice focuses on defending life sciences companies in criminal and civil investigations conducted by the U.S. Department of Justice, U.S. Attorneys’ Offices, state attorneys general, and other government agencies.
Schreck also represents clients in litigation involving the False Claims Act, including actions brought by government authorities and private whistleblowers, commonly known as qui tam relators.
Her experience extends to matters involving the Food, Drug, and Cosmetic Act, the Anti-Kickback Statute, and other federal and state health care laws and regulations. She also conducts large-scale internal investigations involving health care compliance and workplace integrity issues.
The additions reflect Troutman Pepper Locke’s continued investment in its health care and life sciences practice as companies face increasingly complex litigation, regulatory scrutiny, and enforcement challenges.
The firm’s Health Care and Life Sciences Department provides integrated legal services covering corporate transactions, intellectual property, regulatory compliance, government investigations, and litigation.
By adding Ringstad’s mass tort and product liability experience alongside Schreck’s government investigations and health care enforcement expertise, the firm is expanding its ability to represent pharmaceutical manufacturers, medical device companies, and other life sciences organizations across interconnected legal matters.
Troutman Pepper Locke has more than 1,600 attorneys across over 30 offices. The firm advises clients in industries including energy, financial services, health care and life sciences, insurance and reinsurance, private equity, and real estate.
KEY QUOTES:
“Health care and life sciences is a key industry sector for the firm, and as litigation work in this space continues to grow in complexity and scale, Andreas and Debra will further strengthen our capabilities in this area. Andreas brings mass tort defense experience forged in the trenches of pharmaceutical and environmental litigation, while Debra brings a track record supporting clients through highly consequential government investigations and litigation matters. Together, they further strengthen our ability to guide clients through any high-stakes dispute they face.”
Sean Fahey, Chair Of Troutman Pepper Locke’s Health Care And Life Sciences Department
“Troutman Pepper Locke has built a destination for top talent in the life sciences space. The opportunity to reunite with former colleagues, including Ryan O’Neil, who joined the firm earlier this year, was a significant draw. I know firsthand the caliber of the firm’s lawyers and look forward to renewing those relationships and contributing to the team’s continued momentum.”
Andreas Ringstad, Partner At Troutman Pepper Locke
“Troutman Pepper Locke’s combination of industry depth, sophisticated litigation experience, regulatory capabilities, and integrated national reach is unique. Life sciences companies are facing evolving enforcement and litigation challenges on many fronts, from FCA litigation and government investigations to product liability exposure. I’m eager to join a nationally recognized firm with the breadth and agility to help clients navigate these interconnected challenges.”
Debra Schreck, Partner At Troutman Pepper Locke

